Research ArticleTheranostics
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
Rudolf A. Werner, Lilja B. Solnes, Mehrbod S. Javadi, Alexander Weich, Michael A. Gorin, Kenneth J. Pienta, Takahiro Higuchi, Andreas K. Buck, Martin G. Pomper, Steven P. Rowe and Constantin Lapa
Journal of Nuclear Medicine July 2018, 59 (7) 1085-1091; DOI: https://doi.org/10.2967/jnumed.117.206631
Rudolf A. Werner
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
3NET Center Würzburg, European Neuroendocrine Tumor Society (ENETS) Center of Excellence (CoE), University Hospital Würzburg, Würzburg, Germany
Lilja B. Solnes
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
Mehrbod S. Javadi
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
Alexander Weich
3NET Center Würzburg, European Neuroendocrine Tumor Society (ENETS) Center of Excellence (CoE), University Hospital Würzburg, Würzburg, Germany
4Department of Internal Medicine II, Gastroenterology, University Hospital Würzburg, Würzburg, Germany
Michael A. Gorin
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
5James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Kenneth J. Pienta
5James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Takahiro Higuchi
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
6Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; and
7Department of Bio Medical Imaging, National Cardiovascular and Cerebral Research Center, Suita, Japan
Andreas K. Buck
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
3NET Center Würzburg, European Neuroendocrine Tumor Society (ENETS) Center of Excellence (CoE), University Hospital Würzburg, Würzburg, Germany
6Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; and
Martin G. Pomper
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
5James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Steven P. Rowe
1Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
5James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Constantin Lapa
2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
3NET Center Würzburg, European Neuroendocrine Tumor Society (ENETS) Center of Excellence (CoE), University Hospital Würzburg, Würzburg, Germany
Abstract
Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.
- 68Ga-DOTATATE/-TOC
- SSTR
- somatostatin receptor
- PET
- PRRT
- peptide receptor radionuclide therapy
- neuroendocrine tumor
- RADS
Footnotes
Published online Mar. 23, 2018.
- © 2018 by the Society of Nuclear Medicine and Molecular Imaging.
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 7
July 1, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
Rudolf A. Werner, Lilja B. Solnes, Mehrbod S. Javadi, Alexander Weich, Michael A. Gorin, Kenneth J. Pienta, Takahiro Higuchi, Andreas K. Buck, Martin G. Pomper, Steven P. Rowe, Constantin Lapa
Journal of Nuclear Medicine Jul 2018, 59 (7) 1085-1091; DOI: 10.2967/jnumed.117.206631
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
Rudolf A. Werner, Lilja B. Solnes, Mehrbod S. Javadi, Alexander Weich, Michael A. Gorin, Kenneth J. Pienta, Takahiro Higuchi, Andreas K. Buck, Martin G. Pomper, Steven P. Rowe, Constantin Lapa
Journal of Nuclear Medicine Jul 2018, 59 (7) 1085-1091; DOI: 10.2967/jnumed.117.206631
Jump to section
Related Articles
Cited By...
- No citing articles found.